Mycobacterium chimaera chorioretinitis preceding central nervous system lesions: a case report and review of the literature.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
22 Jul 2022
Historique:
received: 18 01 2022
accepted: 07 07 2022
entrez: 22 7 2022
pubmed: 23 7 2022
medline: 27 7 2022
Statut: epublish

Résumé

Mycobacterium chimaera ocular infection is a rare disease that is linked to bypass devices used during cardiothoracic surgeries. Reported cases in the literature of ocular involvement preceding CNS involvement are based on clinical exam with no neuroimaging. Here we present a case of M. chimaera ocular infection with no CNS M. chimaera lesions on brain magnetic resonance imaging (MRI). A 59-year-old female presented with altered mental status and blurred vision in February 2021. Her past medical history was significant for aortic valve replacement and ascending aortic aneurysm repair in 2017 complicated by known M. chimaera infection. She had been receiving azithromycin, ethambutol, rifampin, and amikacin as systemic anti-mycobacterium treatment. Her dilated fundus exam showed numerous yellow placoid circular lesions scattered throughout the macula and peripheral retina in both eyes with associated vitritis. Systemic workup, including brain MRI showed no acute infectious lesions. Her infections workup was unremarkable except for a positive toxoplasma IgM, for which she was treated with sulfamethoxazole/trimethoprim. One month later, a head computed tomography showed new numerous scattered round foci of hyperdensity throughout the cerebrum and brainstem thought to be foci of M. chimaera infection. Clofazimine was added per culture and sensitivity. MRI brain 1 month later showed mild decrease in conspicuity and number of these intensities while on anti-mycobacterium treatment. Her cognition had improved at that time as well. She was seen in retina clinic 2 months later where her exam showed similar retinal lesions with no associated vitritis or anterior chamber cell in bilateral eyes, suggesting a lack of active infection. Optical coherence tomography macula showed parafoveal cystoid macular edema bilaterally. She was started on steroidal and non-steroidal anti-inflammatory eye drops. To the best of our knowledge, this is the first case in the literature to report M. chimaera chorioretinitis with concomitant negative neuroimaging. Chorioretinal M. chimaera lesions should motivate high suspicion of CNS involvement prompting early neurological work up.

Sections du résumé

BACKGROUND BACKGROUND
Mycobacterium chimaera ocular infection is a rare disease that is linked to bypass devices used during cardiothoracic surgeries. Reported cases in the literature of ocular involvement preceding CNS involvement are based on clinical exam with no neuroimaging. Here we present a case of M. chimaera ocular infection with no CNS M. chimaera lesions on brain magnetic resonance imaging (MRI).
CASE PRESENTATION METHODS
A 59-year-old female presented with altered mental status and blurred vision in February 2021. Her past medical history was significant for aortic valve replacement and ascending aortic aneurysm repair in 2017 complicated by known M. chimaera infection. She had been receiving azithromycin, ethambutol, rifampin, and amikacin as systemic anti-mycobacterium treatment. Her dilated fundus exam showed numerous yellow placoid circular lesions scattered throughout the macula and peripheral retina in both eyes with associated vitritis. Systemic workup, including brain MRI showed no acute infectious lesions. Her infections workup was unremarkable except for a positive toxoplasma IgM, for which she was treated with sulfamethoxazole/trimethoprim. One month later, a head computed tomography showed new numerous scattered round foci of hyperdensity throughout the cerebrum and brainstem thought to be foci of M. chimaera infection. Clofazimine was added per culture and sensitivity. MRI brain 1 month later showed mild decrease in conspicuity and number of these intensities while on anti-mycobacterium treatment. Her cognition had improved at that time as well. She was seen in retina clinic 2 months later where her exam showed similar retinal lesions with no associated vitritis or anterior chamber cell in bilateral eyes, suggesting a lack of active infection. Optical coherence tomography macula showed parafoveal cystoid macular edema bilaterally. She was started on steroidal and non-steroidal anti-inflammatory eye drops.
CONCLUSIONS CONCLUSIONS
To the best of our knowledge, this is the first case in the literature to report M. chimaera chorioretinitis with concomitant negative neuroimaging. Chorioretinal M. chimaera lesions should motivate high suspicion of CNS involvement prompting early neurological work up.

Identifiants

pubmed: 35869478
doi: 10.1186/s12886-022-02528-2
pii: 10.1186/s12886-022-02528-2
pmc: PMC9308188
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

316

Informations de copyright

© 2022. The Author(s).

Références

Int J Syst Evol Microbiol. 2004 Jul;54(Pt 4):1277-1285
pubmed: 15280303
J Clin Microbiol. 2013 Jun;51(6):1769-73
pubmed: 23536407
Clin Microbiol Infect. 2018 Nov;24(11):1164-1170
pubmed: 29803845
Can J Anaesth. 2017 May;64(5):513-516
pubmed: 28035639
Euro Surveill. 2016 Nov 17;21(46):
pubmed: 27918256
Eur Heart J. 2015 Oct 21;36(40):2745-53
pubmed: 26188001
Infect Control Hosp Epidemiol. 2017 Jan;38(1):103-108
pubmed: 27839530
Emerg Infect Dis. 2018 Mar;24(3):576-578
pubmed: 29460746
Clin Infect Dis. 2015 Jul 1;61(1):67-75
pubmed: 25761866
Curr Opin Infect Dis. 2017 Aug;30(4):388-394
pubmed: 28538044
Euro Surveill. 2016 Apr 28;21(17):
pubmed: 27168588
Clin Infect Dis. 2019 Mar 19;68(7):1244-1250
pubmed: 30371755
Open Forum Infect Dis. 2016 Jun 16;3(3):ofw131
pubmed: 27703994
Ophthalmology. 2017 Feb;124(2):178-188
pubmed: 27871762
Ophthalmol Retina. 2021 Feb;5(2):184-194
pubmed: 32623074
Front Med (Lausanne). 2020 Jun 16;7:243
pubmed: 32613002
Postgrad Med. 2020 Mar;132(2):167-171
pubmed: 31766930
Open Forum Infect Dis. 2021 Jul 01;8(8):ofab348
pubmed: 34377729
Can J Ophthalmol. 2022 Apr;57(2):90-97
pubmed: 33775595
J Hosp Infect. 2020 Feb;104(2):214-235
pubmed: 31715282
Clin Infect Dis. 2020 Feb 3;70(4):692-695
pubmed: 31247065
Klin Monbl Augenheilkd. 2020 Apr;237(4):493-496
pubmed: 32219781
Retina. 2019 Mar;39(3):452-464
pubmed: 29206759
Int J Legal Med. 2021 Nov;135(6):2667-2679
pubmed: 34185152
J Clin Med. 2021 Sep 16;10(18):
pubmed: 34575289
N Engl J Med. 2017 Feb 9;376(6):600-602
pubmed: 28177865

Auteurs

Aaron Veenis (A)

Department of Ophthalmology, University of Kansas School of Medicine, 7400 State Line Rd, Prairie Village, Kansas, KS, 66208, USA.

Megan Haghnegahdar (M)

Department of Ophthalmology, University of Kansas School of Medicine, 7400 State Line Rd, Prairie Village, Kansas, KS, 66208, USA.

Radwan Ajlan (R)

Department of Ophthalmology, University of Kansas School of Medicine, 7400 State Line Rd, Prairie Village, Kansas, KS, 66208, USA. rajlan@kumc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH